GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

MRBK · Mar 31, 2025

Meridian Corp. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001750735-25-000039Bank
Sequential deposit growth75thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.deposits

6.15% · CORE · VALID

Net-income growth50thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.net_income

-10.35% · CORE · VALID

Interest-income growth5thOwn-history percentile · N=20
Evidence method

Yoy · gp.financial.interest_income

5.25% · CORE · VALID

Cash and equivalents100thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$131.2M · CORE · VALID

Sequential loan growth45thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.loans

1.93% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History31 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Increased
Previous
1.34%
Current
6.15%
Delta
4.82%
Earnings Growth Decreased
Previous
23.43%
Current
-10.35%
Delta
-33.78%
Interest Income Growth Decreased
Previous
14.23%
Current
5.25%
Delta
-8.98%
Liquidity Increased
Previous
$27.5M
Current
$131.2M
Delta
$103.8M
Loan Growth Increased
Previous
1.29%
Current
1.93%
Delta
0.64%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.